AcelRx Announces Primary Endpoint Met in Phase 3 Non-Inferiority Study of Sublingual Sufentanil NanoTab PCA System vs. IV PCA Morphine for Post-Operative Pain -In this open-label study, the Sufentanil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results